1688O Informative censoring of surrogate end-point data in FDA-approved cancer drugs
DOI:
10.1016/j.annonc.2023.09.2642
Publication Date:
2023-10-20T13:08:36Z
AUTHORS (5)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....